A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing

Achieving spatial control of gene expression is important. Here the authors report an optimised photoactivatable Cre recombinase system, doxycycline- and light-inducible Cre recombinase (DiLiCre), and generate a DiLiCre mouse line which they use for mutagenesis in vivo and positional cell-tracing.

Bibliographic Details
Main Authors: Miguel Vizoso, Colin E. J. Pritchard, Lorenzo Bombardelli, Bram van den Broek, Paul Krimpenfort, Roderick L. Beijersbergen, Kees Jalink, Jacco van Rheenen
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-33863-z
_version_ 1797991647959580672
author Miguel Vizoso
Colin E. J. Pritchard
Lorenzo Bombardelli
Bram van den Broek
Paul Krimpenfort
Roderick L. Beijersbergen
Kees Jalink
Jacco van Rheenen
author_facet Miguel Vizoso
Colin E. J. Pritchard
Lorenzo Bombardelli
Bram van den Broek
Paul Krimpenfort
Roderick L. Beijersbergen
Kees Jalink
Jacco van Rheenen
author_sort Miguel Vizoso
collection DOAJ
description Achieving spatial control of gene expression is important. Here the authors report an optimised photoactivatable Cre recombinase system, doxycycline- and light-inducible Cre recombinase (DiLiCre), and generate a DiLiCre mouse line which they use for mutagenesis in vivo and positional cell-tracing.
first_indexed 2024-04-11T08:55:28Z
format Article
id doaj.art-ca99867f51bf4b11a30935fbe673b977
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-11T08:55:28Z
publishDate 2022-10-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-ca99867f51bf4b11a30935fbe673b9772022-12-22T04:33:19ZengNature PortfolioNature Communications2041-17232022-10-0113111510.1038/s41467-022-33863-zA doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editingMiguel Vizoso0Colin E. J. Pritchard1Lorenzo Bombardelli2Bram van den Broek3Paul Krimpenfort4Roderick L. Beijersbergen5Kees Jalink6Jacco van Rheenen7Department of Molecular Pathology, Oncode Institute, Netherlands Cancer InstituteMouse Clinic for Cancer and Aging, The Netherlands Cancer InstituteDivision of Molecular Carcinogenesis and Oncode Institute, Netherlands Cancer InstituteCell Biophysics Group, Department of Cell Biology, The Netherlands Cancer InstituteMouse Clinic for Cancer and Aging, The Netherlands Cancer InstituteDivision of Molecular Carcinogenesis and Oncode Institute, Netherlands Cancer InstituteCell Biophysics Group, Department of Cell Biology, The Netherlands Cancer InstituteDepartment of Molecular Pathology, Oncode Institute, Netherlands Cancer InstituteAchieving spatial control of gene expression is important. Here the authors report an optimised photoactivatable Cre recombinase system, doxycycline- and light-inducible Cre recombinase (DiLiCre), and generate a DiLiCre mouse line which they use for mutagenesis in vivo and positional cell-tracing.https://doi.org/10.1038/s41467-022-33863-z
spellingShingle Miguel Vizoso
Colin E. J. Pritchard
Lorenzo Bombardelli
Bram van den Broek
Paul Krimpenfort
Roderick L. Beijersbergen
Kees Jalink
Jacco van Rheenen
A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing
Nature Communications
title A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing
title_full A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing
title_fullStr A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing
title_full_unstemmed A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing
title_short A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing
title_sort doxycycline and light inducible cre recombinase mouse model for optogenetic genome editing
url https://doi.org/10.1038/s41467-022-33863-z
work_keys_str_mv AT miguelvizoso adoxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT colinejpritchard adoxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT lorenzobombardelli adoxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT bramvandenbroek adoxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT paulkrimpenfort adoxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT rodericklbeijersbergen adoxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT keesjalink adoxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT jaccovanrheenen adoxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT miguelvizoso doxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT colinejpritchard doxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT lorenzobombardelli doxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT bramvandenbroek doxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT paulkrimpenfort doxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT rodericklbeijersbergen doxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT keesjalink doxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting
AT jaccovanrheenen doxycyclineandlightinduciblecrerecombinasemousemodelforoptogeneticgenomeediting